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Background
Early diagnosis of macrophage activations syndrome
(MAS) in systemic juvenile idiopathic arthritis (sJIA)
may be challenging because it may mimic the clinical
features of the underlying disease or be confused with
an infectious complication. However, the diagnostic
value of the guidelines for hemophagocytic lymphohis-
tiocytosis (HLH) (1) or sJIA-associated MAS (2) has sel-
dom been examined.
Objective
To investigate the sensitivity and specificity of diagnostic
guidelines for HLH and sJIA-associated MAS in patients
with sJIA who developed MAS.
Methods
The study sample included 155 children with sJIA who
had MAS (diagnosed and treated as such by the attend-
ing physician) and 2 control groups with potentially
“confusable” conditions, including active sJIA without
MAS (n=303) and a systemic febrile infection requiring
hospitalization (n=191). Diagnostic guidelines for HLH
and sJIA-associated MAS were applied to all MAS and
control patients. Because no patient had NK-cell activity
and soluble CD25 determination available and bone
marrow aspirate was performed in only a few patients,
these 3 criteria were excluded from HLH guidelines.
HLH criteria were, therefore, met when at least 4 of the
5 remaining variables were present. sJIA-associated
MAS criteria were met when at least 2 laboratory
criteria or at least 1 laboratory criterion and 1 clinical
criterion were present. Sensitivity and specificity of
guidelines in discriminating patients with MAS from
control patients were assessed.
Results
The table shows the comparison of sensitivity and speci-
ficity of diagnostic guidelines.
Conclusions
The diagnostic guidelines for sJIA-associated MAS
revealed strong sensitivity and specificity, whereas HLH
guidelines were highly specific, but lacked sensitivity.
Sensitivity of HLH was mostly hampered by the exces-
sive stringent threshold for cytopenia and hypofibrino-
genemia, and the infrequent occurrence of splenomegaly
in patients with MAS.
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(For the) Investigator Consortium for MAS Diagnostic Guidelines
Table 1
Diagnostic guidelines MAS vs. active sJIA MAS vs. systemic
infection
Sensitivity Specificity Sensitivity Specificity
HLH 0.26 1 0.26 0.98
sJIA-associated MAS 0.87 0.91 0.87 0.85
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